Perjeta: Data Supports Fast Approval For Breast Cancer Drug, FDA Reviewers Say
Category: WELLNESS
Since there are no approved neoadjuvant breast cancer treatments, there is technically no standard of care. However, the
By Reuters, Reuters, 2013-09-10